HongKong Curegene Innovation Co., Limited

Established in 2018 in Zhangjiang Hi-Tech Park, Shanghai, CureGene Pharmaceutical is a global-oriented innovative biotech firm concentrating on two core therapeutic areas: cardio-cerebrovascular diseases and antiviral infectious diseases. We have built two world-leading self-owned technology platforms: A-proX™ AI Prodrug Platform and CureGene-X1 mRNA Therapeutic Platform, supporting the full-cycle discovery, preclinical and clinical development of differentiated First-in-Class/Best-in-Class drug